TD Asset Management Inc lessened its holdings in Stevanato Group S.p.A. (NYSE:STVN - Free Report) by 28.6% during the 2nd quarter, according to its most recent Form 13F filing with the SEC. The fund owned 80,932 shares of the company's stock after selling 32,400 shares during the period. TD Asset Management Inc's holdings in Stevanato Group were worth $1,977,000 at the end of the most recent quarter.
Several other large investors also recently bought and sold shares of the business. Lindenwold Advisors INC bought a new stake in Stevanato Group in the second quarter worth $229,000. Bar Harbor Wealth Management bought a new position in Stevanato Group during the second quarter valued at $9,081,000. Hilltop National Bank bought a new position in Stevanato Group during the second quarter valued at $158,000. Truist Financial Corp increased its position in Stevanato Group by 9.5% during the second quarter. Truist Financial Corp now owns 32,029 shares of the company's stock valued at $782,000 after acquiring an additional 2,781 shares during the last quarter. Finally, Diversified Trust Co bought a new position in Stevanato Group during the second quarter valued at $352,000.
Stevanato Group Trading Up 1.9%
NYSE STVN opened at €26.34 on Wednesday. The company's 50-day moving average price is €24.62 and its 200-day moving average price is €23.77. The company has a current ratio of 1.79, a quick ratio of 1.22 and a debt-to-equity ratio of 0.25. The stock has a market cap of $7.98 billion, a PE ratio of 48.79, a PEG ratio of 2.43 and a beta of 0.57. Stevanato Group S.p.A. has a 12 month low of €17.12 and a 12 month high of €28.00.
Analysts Set New Price Targets
A number of research analysts have weighed in on STVN shares. William Blair reiterated an "outperform" rating on shares of Stevanato Group in a research report on Monday, June 30th. Weiss Ratings reiterated a "hold (c)" rating on shares of Stevanato Group in a research report on Wednesday, October 8th. One investment analyst has rated the stock with a Strong Buy rating, three have given a Buy rating and three have assigned a Hold rating to the company's stock. Based on data from MarketBeat, the company has an average rating of "Moderate Buy".
Get Our Latest Stock Analysis on STVN
Stevanato Group Company Profile
(
Free Report)
Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering.
Featured Articles
Want to see what other hedge funds are holding STVN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Stevanato Group S.p.A. (NYSE:STVN - Free Report).
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Stevanato Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Stevanato Group wasn't on the list.
While Stevanato Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
